Electra Therapeutics
$183.0M
Funding date
Valuation / Funding
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| October 22, 2025 | Later Stage VC (Series C) | $183.0M | N/A | - |
| February 16, 2022 | Early Stage VC (Series B) | $84.0M | N/A | - |
Current Valuation Metrics
Electra Therapeutics is currently valued at $479.0M as of October 15, 2025. The company has raised a total of $301.0M in funding across 2 funding rounds.
Capital Efficiency
With a capital efficiency ratio of 1.59x, Electra Therapeutics has achieved a valuation that is 1.59 times the total capital raised.
What is Electra Therapeutics Worth in 2026?
Electra Therapeutics is a leading private company in the Drug Discovery sector. Track Electra Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Electra Therapeutics Valuation is Determined
Private company valuations like Electra Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.